Protein Binding as a Primary Determinant of the Clinical Pharmacokinetic Properties of Non-Steroidal Anti-Inflammatory Drugs
- 1 June 1987
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 12 (6) , 402-432
- https://doi.org/10.2165/00003088-198712060-00002
Abstract
The ability of a wide variety of anionic, cationic, and neutral drugs to bind in a reversible manner to plasma proteins has long been recognised. Non-steroidal anti-inflammatory drugs (NSAIDs) are...Keywords
This publication has 98 references indexed in Scilit:
- Pharmacokinetics of Carprofen in Plasma and Synovial FluidThe Journal of Clinical Pharmacology, 1979
- Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.British Journal of Clinical Pharmacology, 1979
- Role of concentration-dependent plasma protein binding in disopyramide dispositionJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Interaction of Sulindac and Metabolite with Human Serum AlbuminJournal of Pharmaceutical Sciences, 1978
- Diseases and Drug Protein BindingClinical Pharmacokinetics, 1978
- Plasma concentration of phenylbutazone and its therapeutic effect- studies in patients with rheumatoid arthritis.Published by Wiley ,1976
- Drug Protein Binding and the Nephrotic SyndromeClinical Pharmacokinetics, 1976
- Protein Binding of Drugs in Plasma from Patients with Acute Renal FailureActa Pharmacologica et Toxicologica, 1973
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Protein-binding of small molecules: New gel filtration methodJournal of Pharmacy and Pharmacology, 1968